DETROIT, MI--(Marketwire - Dec 4, 2012) - Nano Labs Corp. (
Mr. Licari has over 20 years of experience in international marketing, sales and business development. He has held various management positions with global companies such as AT&T Canada, Tyco Healthcare, Valleylab, Arton Capital and Monster Worldwide in the markets of North America, Europe, the Middle East and Africa (EMEA).
"Stephan brings a wealth of international development knowledge to the table. He has a strong track record in helping companies grow and transform their businesses by integrating new technologies," said Mr. Bernardo Camacho Chavarria, President of Nano Labs. "He will be a great asset to the team here at Nano Labs, and I look forward to working closely with him as we explore markets here in North America and abroad."
Mr. Licari will be responsible for driving the sales team and growth of Nano Labs by introducing its cutting edge nano technologies to the global marketplace. He has built and organized teams to generate new revenue on three different continents.
"I look forward to taking hold of the immense growth opportunities presented through Nano Labs' IP treasure chest, and to working closely with senior management and the Board of Directors. My immediate goals are to address and manage the growing list of strategic relationships and alliances the company currently is developing. We are looking to leverage our intellectual property and marry the work with the proper expertise and channels to bring our new products to market," stated Mr. Licari.
Mr. Licari's business-development activities will focus on cultivating relationships with companies, organizations and governments to work with the Company on strategic, commercial, and joint-venture programs.
Nano Labs defines the three programs as follows:
> Strategic Partnerships focus on promoting partnerships with academic and government entities to further the commercial development of nanotechnology.
> Commercial Partnerships focus on the industrial commercialization of our products and the licensing of a diverse range of our in-house, intellectual property assets to create new products for mass commercialization.
> Joint Ventures focus on cooperative financial investments to commercialize new products and channels.
"On behalf of the Company, I cordially invite all interested parties to explore the unique capabilities of Nano Labs and the potential of nanotechnology. Our innovative products and services are available for licensing by category and/or by territory, and we are looking for long-term relationships with key licensing and distribution partners. This may include assigning patents, licensing patents for a field of use, technology transfer, copyrights, royalty agreements, buying a product line, and other methods. As well, we design our partner programs to include milestones and performance-based metrics to maximize the value of these programs for our partners and our shareholders," Mr. Licari said.
Mr. Licari holds a Bachelor of Business Administration in Marketing and International Management from the Ecole des Hautes Etudes Commerciales (HEC) in Montreal, Quebec.
About Nano Labs
Nano Labs Corp. (CTLE) is a nanotechnology research and development company which began during October 2012, but is able to access resources that encompass nearly 30 years of research and development in nanotechnology as well as hundreds of peer-reviewed and published research papers and other scholarly material.
The Company's research and development team of scientists, designers, and engineers is focused on creating a portfolio of advanced products that could provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare. Through the use and integration of proprietary nano compounds, our goal is to evolve common products into new, revolutionary products in order to make the world a better place.
Nano Labs shares are traded on the OTC Bulletin Board in the United States under the ticker CTLE.
For more information, please visit www.NanoLabs.us.
Forward looking statements
This press release contains forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those laws. These forward-looking statements are based upon a number of assumptions and estimates that are subject to significant uncertainties that involve known and unknown risks, many of which are beyond our control and are not guarantees of future performance. Actual outcomes and results could materially differ from what is expressed, implied, or forecasted in any such forward-looking statements and any such difference may be caused by risk factors listed from time to time in the Company's news releases and/or its filings with the OTC Bulletin Board or as a result of other factors.